SARA CARRIER: Open Payments
NPI 1275536336 · CONCORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 55 payments from 16 companies in 2025. Trend: 2023 $230 · 2024 $937 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $512 |
| PFIZER INC. | 11 | $182 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Novo Nordisk Inc | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $35 |
| ABIOMED | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: UBRELVY, QULIPTA, ELIQUIS, GARDASIL 9, NURTEC ODT, Ozempic, AIRSUPRA, VRAYLAR.
Industry payments across NH — which companies pay providers there.
